PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
05-Jun-2022 Adjuvant Treatment With Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Statistically Significant & Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients With Resected Stage IIB or IIC Melanoma in Phase 3 KEYNOTE-716 Trial Businesswire
05-Jun-2022 Creatv Bio’s LifeTracDx® Liquid Biopsy Predicts Response to New Line of Therapy for Metastatic Breast Cancer within 30 Days Businesswire
04-Jun-2022 MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2022 Businesswire
04-Jun-2022 CG Oncology Presents New Clinical Data on Two Ongoing Programs at The American Society of Clinical Oncology (ASCO) 2022 Annual Meeting Businesswire
04-Jun-2022 Nucleai to Publish Pathology-based Data at ASCO 2022 for Phase 2 Research of the Most Common Type of Non-Hodgkin’s Lymphoma Businesswire
04-Jun-2022 Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT ‘Basket’ Trial of Neratinib at the ASCO 2022 Annual Meeting Businesswire
04-Jun-2022 Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable Responses with Ciltacabtagene Autoleucel Across Lines of Therapy in Patients with Multiple Myeloma Businesswire
04-Jun-2022 Atara Biotherapeutics Announces First Clinical Data from Ongoing Tab-cel® European Multicenter Expanded Access Program (EAP) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting and Update on Tab-cel EMA Regulatory Progress Businesswire
04-Jun-2022 ABBVIE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AbbVie, Inc. and Encourages Investors to Contact the Firm Businesswire
04-Jun-2022 Cybin Announces Additional Adelia Milestone Achievements Businesswire
03-Jun-2022 Bristol Myers Squibb Withdraws Supplemental Biologics License Application (sBLA) for Reblozyl® (luspatercept-aamt) for Non-transfusion Dependent (NTD) Beta Thalassemia Businesswire
03-Jun-2022 United Therapeutics Corporation to Present at the Jefferies Healthcare Conference Businesswire
03-Jun-2022 Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Businesswire
03-Jun-2022 Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Businesswire
03-Jun-2022 Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Businesswire
03-Jun-2022 ADCETRIS® (brentuximab vedotin) Plus Standard of Care Chemotherapy Demonstrates Superior Event-Free Survival (EFS) vs. Standard of Care Alone in Children and Young Adults with Previously Untreated High-Risk Hodgkin Lymphoma Businesswire
03-Jun-2022 Biophytis: Convening of Another Combined General Meeting at a Later Date Biophytis
03-Jun-2022 Baron & Budd Obtains Largest Asbestos Related Judgment in Louisiana Businesswire
03-Jun-2022 Call for Presentations Open for the 2022 DeviceTalks West Conference & Expo Businesswire
03-Jun-2022 Daiwa Health Development to Present Top Products at Webinar Businesswire